These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20801099)

  • 1. Microparticles mediate enzyme transfer from platelets to mast cells: a new pathway for lipoxin A4 biosynthesis.
    Tang K; Liu J; Yang Z; Zhang B; Zhang H; Huang C; Ma J; Shen GX; Ye D; Huang B
    Biochem Biophys Res Commun; 2010 Sep; 400(3):432-6. PubMed ID: 20801099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoxin A4 and lipoxin B4 stimulate the release but not the oxygenation of arachidonic acid in human neutrophils: dissociation between lipid remodeling and adhesion.
    Nigam S; Fiore S; Luscinskas FW; Serhan CN
    J Cell Physiol; 1990 Jun; 143(3):512-23. PubMed ID: 2162850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart.
    Birnbaum Y; Ye Y; Lin Y; Freeberg SY; Huang MH; Perez-Polo JR; Uretsky BF
    Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):89-98. PubMed ID: 17259075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoxins, leukocyte recruitment and the resolution phase of acute glomerulonephritis.
    O'Meara YM; Brady HR
    Kidney Int Suppl; 1997 Mar; 58():S56-61. PubMed ID: 9067945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoxin A4 inhibits acute edema in mice: implications for the anti-edematogenic mechanism induced by aspirin.
    Menezes-de-Lima O; Kassuya CA; Nascimento AF; Henriques Md; Calixto JB
    Prostaglandins Other Lipid Mediat; 2006 Sep; 80(3-4):123-35. PubMed ID: 16939877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of human monocytes and the acute monocytic leukemia cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 versus lipoxin B4: evidence for differential Ca2+ mobilization.
    Romano M; Maddox JF; Serhan CN
    J Immunol; 1996 Sep; 157(5):2149-54. PubMed ID: 8757340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis.
    Hashimoto A; Hayashi I; Murakami Y; Sato Y; Kitasato H; Matsushita R; Iizuka N; Urabe K; Itoman M; Hirohata S; Endo H
    J Rheumatol; 2007 Nov; 34(11):2144-53. PubMed ID: 17918787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of lipoxins by combined gas chromatography and electron-capture negative ion chemical ionization mass spectrometry: formation of lipoxin A4 by stimulated human whole blood.
    Brezinski DA; Serhan CN
    Biol Mass Spectrom; 1991 Feb; 20(2):45-52. PubMed ID: 1883860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoxin synthase activity of human platelet 12-lipoxygenase.
    Romano M; Chen XS; Takahashi Y; Yamamoto S; Funk CD; Serhan CN
    Biochem J; 1993 Nov; 296 ( Pt 1)(Pt 1):127-33. PubMed ID: 8250832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoxin A(4) reduces lipopolysaccharide-induced inflammation in macrophages and intestinal epithelial cells through inhibition of nuclear factor-kappaB activation.
    Kure I; Nishiumi S; Nishitani Y; Tanoue T; Ishida T; Mizuno M; Fujita T; Kutsumi H; Arita M; Azuma T; Yoshida M
    J Pharmacol Exp Ther; 2010 Feb; 332(2):541-8. PubMed ID: 19846590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution.
    Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):141-62. PubMed ID: 16005201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of lipoxin A4 receptor by thromboxane A2 signaling in RAW246.7 cells in vitro and bleomycin-induced lung fibrosis in vivo.
    Sato Y; Kitasato H; Murakami Y; Hashimoto A; Endo H; Kondo H; Inoue M; Hayashi I
    Biomed Pharmacother; 2004; 58(6-7):381-7. PubMed ID: 15271420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of myocardial production of 15-epi-lipoxin-a4 by pioglitazone and atorvastatin in the rat.
    Birnbaum Y; Ye Y; Lin Y; Freeberg SY; Nishi SP; Martinez JD; Huang MH; Uretsky BF; Perez-Polo JR
    Circulation; 2006 Aug; 114(9):929-35. PubMed ID: 16908763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production.
    Bafica A; Scanga CA; Serhan C; Machado F; White S; Sher A; Aliberti J
    J Clin Invest; 2005 Jun; 115(6):1601-6. PubMed ID: 15931391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA.
    Chiang N; Takano T; Clish CB; Petasis NA; Tai HH; Serhan CN
    J Pharmacol Exp Ther; 1998 Nov; 287(2):779-90. PubMed ID: 9808710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-generation beta-oxidation resistant 3-oxa-lipoxin A4 analogs.
    Guilford WJ; Parkinson JF
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):245-50. PubMed ID: 15985364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between lipoxin A4, the stable analogue 16-phenoxy-lipoxin A4 and leukotriene B4 in cytokine generation by human monocytes.
    Andersson P; Serhan CN; Petasis NA; Palmblad J
    Scand J Immunol; 2004 Sep; 60(3):249-56. PubMed ID: 15320881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoxin biosynthesis in inflammatory bowel disease.
    Mangino MJ; Brounts L; Harms B; Heise C
    Prostaglandins Other Lipid Mediat; 2006 Mar; 79(1-2):84-92. PubMed ID: 16516812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual role of lipoxin A4 in pneumosepsis pathogenesis.
    Sordi R; Menezes-de-Lima O; Horewicz V; Scheschowitsch K; Santos LF; Assreuy J
    Int Immunopharmacol; 2013 Oct; 17(2):283-92. PubMed ID: 23816538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Lipoxygenase-derived lipid mediators are not required for the development of NSAID-induced inflammatory bowel disease in IL-10-/- mice.
    Narushima S; DiMeo D; Tian J; Zhang J; Liu D; Berg DJ
    Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G477-88. PubMed ID: 18048478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.